Articles dans des revues avec comité de lecture (58)
1.
Negueruela Escudero, J., Vandenbempt, V., Talamantes, S., Ribeiro-Costa, F., Nunes, M., Marques Dias, A., Bansal, M., & Gurzov, E. N. (2024). Protocol for CRISPR-Cas12a genome editing of protein tyrosine phosphatases in human pluripotent stem cells and functional β-like cell generation. STAR Protocols, 5(3), 103297. doi:10.1016/j.xpro.2024.1032972.
Vandenbempt, V., Eski, S. E., Brahma, M. K., Li, A., Negueruela Escudero, J., Bruggeman, Y., Demine, S., Xiao, P., Cardozo, A. K., Baeyens, N., Martelotto, L., Singh, S. P., Mariño, E., Gysemans, C., & Gurzov, E. N. (2023). HAMSAB diet ameliorates dysfunctional signaling in pancreatic islets in autoimmune diabetes. iScience, 27(1), 108694. doi:10.1016/j.isci.2023.1086943.
Talamantes, S., Lisjak, M., Gilglioni, E. H., Llamoza-Torres, C., Ramos-Molina, B., & Gurzov, E. N. (2023). Non-alcoholic fatty liver disease and diabetes mellitus as growing aetiologies of hepatocellular carcinoma. JHEP Reports, 100811. doi:10.1016/j.jhepr.2023.1008114.
Takiishi, T., Xiao, P., Franchimont, M., Gilglioni, E. H., Arroba, E., Gurzov, E. N., Bertrand, M., & Cardozo, A. K. (2023). Inhibition of RIPK1 kinase does not affect diabetes development: β-Cells survive RIPK1 activation. Molecular metabolism, 69, 101681. doi:10.1016/j.molmet.2023.1016815.
Bell, K. K., Saad, S., Tillett, B. B., McGuire, H. H., Bordbar, S., Yap, Y. A., Nguyen, L. T., Wilkins, M. M., Corley, S., Brodie, S., Duong, S., Wright, C. C., Twigg, S., de St Groth, B. F., Harrison, L. L., Mackay, C. R., Gurzov, E. N., Hamilton-Williams, E. E., & Mariño, E. (2022). Metabolite-based dietary supplementation in human type 1 diabetes is associated with microbiota and immune modulation. Microbiome, 10(1), 9. doi:10.1186/s40168-021-01193-96.
Brahma, M. K., Xiao, P., Popa, M., Negueruela Escudero, J., Vandenbempt, V., Demine, S., Cardozo, A. K., & Gurzov, E. N. (2022). Nova1 or Bim Deficiency in Pancreatic β-Cells Does Not Alter Multiple Low-Dose Streptozotocin-Induced Diabetes and Diet-Induced Obesity in Mice. Nutrients, 14(18). doi:10.3390/nu141838667.
Xiao, P., Takiishi, T., Moretti Violato, N., Licata, G., Dotta, F., Sebastiani, G., MARSELLI, L., Singh, S. P., Sze, M., Van Loo, G., Dejardin, E., Gurzov, E. N., & Cardozo, A. K. (2022). NF-kappaB-inducing kinase (NIK) is activated in pancreatic beta-cells but does not contribute to the development of diabetes. Cell death & disease, 13(5). doi:10.1038/s41419-022-04931-58.
Elvira Jimenez, B., Vandenbempt, V., Bauzá-Martinez, J., Crutzen, R., Negueruela, J., Ibrahim, H., Winder, M. M., Brahma, M. K., Vekeriotaite, B., Martens, P.-J., Singh, S. P., Rossello, F., Lybaert, P., Otonkoski, T., Gysemans, C., Wu, W., & Gurzov, E. N. (2022). PTPN2 Regulates the Interferon Signaling and Endoplasmic Reticulum Stress Response in Pancreatic Beta-Cells in Autoimmune Diabetes. Diabetes (New York, N.Y.). doi:10.2337/db21-04439.
Brahma, M. K., Gilglioni, E. H., Zhou, L., Trepo, E., Chen, P., & Gurzov, E. N. (2021). Oxidative stress in obesity-associated hepatocellular carcinoma: sources, signaling and therapeutic challenges. Oncogene. doi:10.1038/s41388-021-01950-y10.
Eriksson, M., Litwak, S. A., Yun, Y., Stanley, W. J., Thorn, P., Ahlgren, U., & Gurzov, E. N. (2021). Insulin-Binding Peptide Probes Provide a Novel Strategy for Pancreatic Beta Cell Imaging. Molecular pharmaceutics. doi:10.1021/acs.molpharmaceut.1c0061611.
Schaschkow, A., Pang, L., Vandenbempt, V., Elvira Jimenez, B., Litwak, S. A., Vekeriotaite, B., Maillard, E., Vermeersch, M., Moura De Paula, F., Pinget, M., Perez-Morga, D., Gough, D. J., & Gurzov, E. N. (2021). STAT3 Regulates Mitochondrial Gene Expression in Pancreatic Beta-Cells and Its Deficiency Induces Glucose Intolerance in Obesity. Diabetes (New York, N.Y.), 70(9), 2026-2041. doi:10.2337/db20-1222